18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Exosomes are vesicles encompassed by a lipid bilayer that are released by various living cells. Exosomal proteins are encapsulated within the membrane or embedded on the surface. As an important type of exosome cargo, exosomal proteins can reflect the physiological status of the parent cell and play an essential role in cell–cell communication. Exosomal proteins can regulate tumor development, including tumor-related immune regulation, microenvironment reconstruction, angiogenesis, epithelial–mesenchymal transition, metastasis, etc. The features of exosomal proteins can provide insight into exosome generation, targeting, and biological function and are potential sources of markers for cancer diagnosis, prognosis, and treatment. Here, we summarize the effects of exosomal proteins on cancer biology, the latest progress in the application of exosomal proteins in cancer diagnosis and prognosis, and the potential contribution of exosomal proteins in cancer therapeutics and vaccines.

          Cancer: exploring the potential of exosomes

          Exosomes, membrane-bound vesicles released by some cells, contain a cargo of proteins and other biomolecules that can be analyzed to assist the diagnosis of cancer or predict its likely outcome, and may become useful in treating cancer. Zhihui Li, Jianyong Lei, and colleagues at Sichuan University, Chengdu, China, review progress in cancer-focused exosome research. The proteins in exosomes can act as indicators of the health or disease status of cells. They can also control the development of tumors and wider physiological processes that support tumor growth and spread. The authors consider the specific significance of exosome proteins in each of a wide range of common human cancers, and discuss some technical challenges that must be overcome to fully exploit the potential of exosomes to diagnose, monitor, and perhaps treat cancer.

          Related collections

          Most cited references144

          • Record: found
          • Abstract: found
          • Article: not found

          The biology, function, and biomedical applications of exosomes

          The study of extracellular vesicles (EVs) has the potential to identify unknown cellular and molecular mechanisms in intercellular communication and in organ homeostasis and disease. Exosomes, with an average diameter of ~100 nanometers, are a subset of EVs. The biogenesis of exosomes involves their origin in endosomes, and subsequent interactions with other intracellular vesicles and organelles generate the final content of the exosomes. Their diverse constituents include nucleic acids, proteins, lipids, amino acids, and metabolites, which can reflect their cell of origin. In various diseases, exosomes offer a window into altered cellular or tissue states, and their detection in biological fluids potentially offers a multicomponent diagnostic readout. The efficient exchange of cellular components through exosomes can inform their applied use in designing exosome-based therapeutics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hepatocellular carcinoma

            Hepatocellular carcinoma appears frequently in patients with cirrhosis. Surveillance by biannual ultrasound is recommended for such patients because it allows diagnosis at an early stage, when effective therapies are feasible. The best candidates for resection are patients with a solitary tumour and preserved liver function. Liver transplantation benefits patients who are not good candidates for surgical resection, and the best candidates are those within Milan criteria (solitary tumour ≤5 cm or up to three nodules ≤3 cm). Image-guided ablation is the most frequently used therapeutic strategy, but its efficacy is limited by the size of the tumour and its localisation. Chemoembolisation has survival benefit in asymptomatic patients with multifocal disease without vascular invasion or extrahepatic spread. Finally, sorafenib, lenvatinib, which is non-inferior to sorafenib, and regorafenib increase survival and are the standard treatments in advanced hepatocellular carcinoma. This Seminar summarises the scientific evidence that supports the current recommendations for clinical practice, and discusses the areas in which more research is needed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tumour exosome integrins determine organotropic metastasis

              Ever since Stephen Paget’s 1889 hypothesis, metastatic organotropism has remained one of cancer’s greatest mysteries. Here we demonstrate that exosomes from mouse and human lung-, liver- and brain-tropic tumour cells fuse preferentially with resident cells at their predicted destination, namely lung fibroblasts and epithelial cells, liver Kupffer cells and brain endothelial cells. We show that tumour-derived exosomes uptaken by organ-specific cells prepare the pre-metastatic niche. Treatment with exosomes from lung-tropic models redirected the metastasis of bone-tropic tumour cells. Exosome proteomics revealed distinct integrin expression patterns, in which the exosomal integrins α6β4 and α6β1 were associated with lung metastasis, while exosomal integrin αvβ5 was linked to liver metastasis. Targeting the integrins α6β4 and αvβ5 decreased exosome uptake, as well as lung and liver metastasis, respectively. We demonstrate that exosome integrin uptake by resident cells activates Src phosphorylation and pro-inflammatory S100 gene expression. Finally, our clinical data indicate that exosomal integrins could be used to predict organ-specific metastasis.
                Bookmark

                Author and article information

                Contributors
                rockoliver@vip.sina.com
                leijianyong@scu.edu.cn
                Journal
                Exp Mol Med
                Exp Mol Med
                Experimental & Molecular Medicine
                Nature Publishing Group UK (London )
                1226-3613
                2092-6413
                22 September 2022
                22 September 2022
                September 2022
                : 54
                : 9
                : 1390-1400
                Affiliations
                GRID grid.412901.f, ISNI 0000 0004 1770 1022, Thyroid Surgery Center, , West China Hospital of Sichuan University, ; Chengdu, China
                Article
                855
                10.1038/s12276-022-00855-4
                9535014
                36138197
                84f1c591-aab3-4d9c-9ea4-cc7a3c19991b
                © The Author(s) 2022

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 8 May 2022
                : 29 June 2022
                : 21 July 2022
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001809, National Natural Science Foundation of China (National Science Foundation of China);
                Award ID: 82173245
                Award Recipient :
                Funded by: Post-Doctor Research Project, West China Hospital, Sichuan University (2019HXBH043), Sichuan Science and Technology Program of China (2020YFS0208), the 1•3•5 Project for Disciplines of Excellence-Clinical Research Incubation Project, West China Hospital Sichuan University (2021HXFH005), the Science and Technology Achievement Transformation Project, West China Hospital, Sichuan University (CGZH21004)
                Categories
                Review Article
                Custom metadata
                © The Author(s) 2022

                Molecular medicine
                protein-protein interaction networks,cancer microenvironment
                Molecular medicine
                protein-protein interaction networks, cancer microenvironment

                Comments

                Comment on this article